The ADNP/ketamine trial was the first clinical study generated by a information gleaned from the Precision Medicine Institute’s artificial intelligence tool.

Record $95 million Heersink lead gift to advance strategic growth and biomedical innovation.

The Altec Styslinger Genomic Medicine and Data Sciences Building will help cement UAB’s place as a leading research institution in genomic and precision medicine.